Mobile

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

Mise à jour : Il y a 4 ans
Référence : NCT00694941

Femme et Homme

Extrait

The objective of this study is to investigate the long term safety of ALS patients taking ONO-2506PO.

Critère d'inclusion

  • Amyotrophic Lateral Sclerosis (ALS)

Liens